Skip to main content
. 2022 Apr 27;16:1199–1209. doi: 10.2147/DDDT.S359496

Table 3.

SpO2, HR, MBP and Application of Vasoactive Drugs During Anesthesia (n = 64 in Each Group)

Remimazolam Group Propofol Group Difference (95% CI) P value
SpO2 (%)
Baseline 100.0(1.0) 100.0(1.0) 0.0(0.0 to 0.0) 0.973
1 min after induction 100.0(0.0) 100.0(0.0) 0.0(0.0 to 0.0) 0.440
1 min after intubation 100.0(0.0) 100.0(0.0) 0.0(0.0 to 0.0) 0.156
At the beginning of surgery 100.0(0.0) 100.0(0.0) 0.0(0.0 to 0.0) 0.081
HR (beats/min)
Baseline 77.7±14.7 74.7±12.3 2.9(−1.8 to 7.7) 0.225
1 min after induction 75.5±13.0 65.7±11.5 9.8(5.5 to 14.1) 0.000*
1 min after intubation 74.0(15.8) 66.0(21.8) −9.0(−14.0 to −4.0) 0.001*
At the beginning of surgery 61.0(19.3) 58.5(11.8) −2.0(−6.0 to 2.0) 0.203
MBP (mmHg)
Baseline 108.8±12.6 106.0±12.3 2.8(−1.6 to 7.1) 0.210
1 min after induction 94.4±12.9 87.4±11.9 7.0(2.7 to 11.4) 0.002*
1 min after intubation 93.0(17.0) 93.0(30.8) −2.0(−7.0 to 5.0) 0.642
At the beginning of surgery 86.5(17.0) 86.0(24.0) −1.0(−5.0 to 4.0) 0.800
Application of vasoactive drugs 18.0(28.1%) 36.0(56.3%) 28.1%(11.0% to 43.0%) 0.001*

Notes: Data for HR and MBP at baseline and 1 min after induction were presented as mean ± standard deviation and the difference (95% CI) was the mean difference and its 95% CI. Data for application of vasoactive drugs were presented as number (percentage) and the difference (95% CI) was the proportion difference and its 95% CI. Other data were presented as median (interquartile range), and the difference (95% CI) was the median of all pairwise differences between observations in the two groups, rather than the difference between the group medians. *p < 0.05, compared with propofol group.

Abbreviations: SpO2, pulse oxygen saturation; HR, heart rate; MBP, mean blood pressure; CI, confidence interval.